spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

PCI Pharma Services Announces Bottling Line Expansion to Support Customer Needs

PCI Pharma Services

Rockford IL Commercial Packaging site to add nearly 100 million units of bottling line capacity

Philadelphia, USA – February 5, 2019 PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global biopharmaceutical industry, is pleased to announce the expansion of its bottling line capacity at its Commercial Packaging site in Rockford, IL. Construction of the additional packaging suites began in March 2018 to add considerable footprint for primary and secondary packaging operations equipped with high speed tablet filling, cartoning, as well as in-line serialization and aggregation in support of increased customer demand. The new expansion will grow the robust bottling operation in Rockford by producing an extra 100 million bottles per year.

“I am pleased to share this news regarding our continued investment to support the needs of our customers,” noted Angella Sutthiwan, Vice President and General Manager for PCI’s Rockford location. “Choosing the right contract packaging business partner, one that can consistently and reliably deliver high quality product quickly, while providing the flexibility to manage the peaks and valleys of changing forecasts, is critical to our customers. This multi-million dollar investment demonstrates our commitment to providing both operational flexibility and expansive capacity in meeting those demands in order to bring life-saving medicines to patients around the world.”

PCI’s investment at the Rockford location is the latest in a series of capacity expansion initiatives across its worldwide network, including multiple facility enlargements, Cold Chain and Ultra Cold storage extension, installations of additional packaging lines, as well as significant expansion of its best-in-class Serialization solutions. To further support its existing Biotech infrastructure, PCI’s Commercial Packaging site in Philadelphia, PA recently announced a major $20 million investment in commercial packaging, as well as expanded Cold Chain capacity at numerous global locations.

PCI supports medicines destined to reach more than 100 countries across the world, providing industry-leading services for the clinical and commercial packaging of a diverse portfolio of products and specialized delivery forms. These include, but are not limited to, solid oral dose, powders, semisolids, parenterals and injectibles, with key specialization in potent compounds, cold chain products, controlled substances, and biologics.

To find out more about PCI, please visit here.

About PCI Pharma Services
The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over five decades in the healthcare business. Leading technology and continued investment enable us to address global development needs throughout the product life cycle — from Phase I Clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients’ lives. For more information, please visit www.pciservices.com or follow us on Twitter at @PCI_Social.

Contact

Tom Gosschalk / Claire Oakley at BECG

T: +44 (0)20 3697 7647 / +44 (0)1962 893 918
phone +44 (0)1495 713 633
email sales@pciservices.com
web www.pciservices.com
email Wye Valley Business Park, Hay-on-Wye, HR3 5PG
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Protagen Protein Services and BioAnalytix Merge to Create Global Analytic Service Partner for Biopharmaceuticals

Protagen Protein Services GmbH (PPS), a full-service contract research organization (CRO) in protein analytics and BioAnalytix Inc., a Cambridge (MA)-based specialized provider of advanced analytics in biopharmaceutical development announced today a merger that will transform the combined company into a leading global analytic services provider for the biopharmaceutical industry. Today’s announcement creates a best-in-class partner for biopharmaceutical companies worldwide to benefit from the most advanced, integrated and complete analytic services capabilities in biopharmaceutical development, from clone selection through drug approval to commercialization.
More info >>


White Papers

Investigator Portals: Facilitating and Streamlining Communication & Collaboration with Study Sites

ArisGlobal

ArisGlobal LLC Investigator site personnel are often frustrated with the lack of transparency and communication with their sponsors, leading to significant dissatisfaction and withdrawal from current and future studies. The adoption of investigator portals gives sponsors a platform that fosters collaboration and improves site management. Learn about five key areas of sponsor-investigator site interactions deserving of electronic communication and collaboration. Technology and design aspects are also covered.
More info >>

Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement